What is enlightenVue?
enlightenVue is at the forefront of medical device innovation, having developed a groundbreaking single-use micro-endoscope platform. The surgiVue platform distinguishes itself with the industry's smallest working diameter at 2mm, incorporating multiple working channels for simultaneous diagnostic and therapeutic interventions. Its patented expandable tip technology enhances access for various instruments while maintaining superior optics. With 510(k) clearance, enlightenVue's system is poised for broad adoption across diverse medical specialties and healthcare settings, promising substantial benefits for patients, clinicians, and the overall healthcare system by mitigating infection transmission risks.
How much funding has enlightenVue raised?
enlightenVue has raised a total of $1M across 1 funding round:
Other Financing Round
$1M
Other Financing Round (2022): $1M, investors not publicly disclosed
What's next for enlightenVue?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for enlightenVue. This capital infusion is expected to accelerate market penetration, further research and development into next-generation endoscopic technologies, and potentially expand the company's operational footprint. The focus on a novel platform with dual diagnostic and therapeutic capabilities positions enlightenVue to capture significant market share in the minimally invasive surgery sector, driving future expansion and solidifying its role as a key player in healthcare innovation.
See full enlightenVue company page
